tetramethylrhodamine isothiocyanate has been researched along with chitosan in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cunha-Reis, C; El Haj, AJ; Yang, X; Yang, Y | 1 |
Doliska, A; Kargl, R; Köstler, S; Marn, J; Mohan, T; Ribitsch, V; Ristić, T; Spirk, S; Stana-Kleinschek, K | 1 |
Astete, CE; Coulon, D; Cross, L; Darensbourg, C; Morgan, T; Navarro, SM; Sabliov, CM; Stout, R | 1 |
3 other study(ies) available for tetramethylrhodamine isothiocyanate and chitosan
Article | Year |
---|---|
Fluorescent labeling of chitosan for use in non-invasive monitoring of degradation in tissue engineering.
Topics: Animals; Biocompatible Materials; Body Weight; Cell Line; Chitosan; Disease Models, Animal; Fluorescent Dyes; Humans; Mice; Microscopy, Confocal; Polymers; Regression Analysis; Rhodamines; Solvents; Spectroscopy, Fourier Transform Infrared; Time Factors; Tissue Engineering | 2013 |
Cationically rendered biopolymer surfaces for high protein affinity support matrices.
Topics: Adsorption; Biopolymers; Cellulose; Chitosan; Fluorescein-5-isothiocyanate; Rhodamines; Serum Albumin, Bovine | 2013 |
Biodistribution of PLGA and PLGA/chitosan nanoparticles after repeat-dose oral delivery in F344 rats for 7 days.
Topics: Administration, Oral; Animals; Chemistry, Pharmaceutical; Chitosan; Drug Administration Schedule; Drug Carriers; Fluorescent Dyes; Intestinal Absorption; Lactic Acid; Male; Nanotechnology; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats, Inbred F344; Rhodamines; Surface Properties; Technology, Pharmaceutical; Tissue Distribution | 2014 |